Ruben Osnabrugge is a Director in the EQT Life Sciences team. Ruben worked for LSP from 2021 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Prior to LSP, Ruben led the global value based care strategy of Philips. Before, Ruben worked as a cardiothoracic surgeon at the Erasmus Medical Center in Rotterdam. As part of this training, he also performed general and vascular surgery and worked at the intensive care. He was faculty in several cardiovascular societies, editorial board member, authored >40 articles in top medical journals and was a Fulbright scholar at the Mid-America Heart Institute in Kansas City.
Ruben obtained his MD and PhD degrees from Erasmus Medical School in Rotterdam. He holds a MSc in clinical research from NIHES and the Harvard School of Public Health, and a BSc in health economics from Erasmus School of Economics.